These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34645699)

  • 1. Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden.
    Lauppe RE; Liseth Hansen J; Gerdesköld C; Rozenbaum MH; Strand AM; Vakevainen M; Kuusisto J; Gude E; Gustafsson F; Smith JG
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34645699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, characteristics, and mortality of patients with transthyretin amyloid cardiomyopathy in the Nordic countries.
    Lauppe R; Liseth Hansen J; Fornwall A; Johansson K; Rozenbaum MH; Strand AM; Väkeväinen M; Kuusisto J; Gude E; Smith JG; Gustafsson F
    ESC Heart Fail; 2022 Aug; 9(4):2528-2537. PubMed ID: 35560802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare resource use of patients with transthyretin amyloid cardiomyopathy.
    Lauppe R; Liseth Hansen J; Fornwall A; Johansson K; Rozenbaum MH; Strand AM; Vakevainen M; Kuusisto J; Gude E; Smith JG; Gustafsson F
    ESC Heart Fail; 2022 Jun; 9(3):1636-1642. PubMed ID: 35365974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of transthyretin amyloid cardiomyopathy by automated data extraction from electronic health records.
    Moya A; Oeste CL; Beles M; Verstreken S; Dierckx R; Heggermont W; Bartunek J; Bogaerts E; Masuy I; Hens D; Bertolone D; Vanderheyden M
    ESC Heart Fail; 2023 Dec; 10(6):3483-3492. PubMed ID: 37726928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?
    Aus dem Siepen F; Hein S; Prestel S; Baumgärtner C; Schönland S; Hegenbart U; Röcken C; Katus HA; Kristen AV
    Clin Res Cardiol; 2019 Dec; 108(12):1324-1330. PubMed ID: 30953182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
    Porcari A; Razvi Y; Masi A; Patel R; Ioannou A; Rauf MU; Hutt DF; Rowczenio D; Gilbertson J; Martinez-Naharro A; Venneri L; Whelan C; Lachmann H; Wechalekar A; Quarta CC; Merlo M; Sinagra G; Hawkins PN; Fontana M; Gillmore JD
    Eur J Heart Fail; 2023 Apr; 25(4):515-524. PubMed ID: 36644836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction.
    AbouEzzeddine OF; Davies DR; Scott CG; Fayyaz AU; Askew JW; McKie PM; Noseworthy PA; Johnson GB; Dunlay SM; Borlaug BA; Chareonthaitawee P; Roger VL; Dispenzieri A; Grogan M; Redfield MM
    JAMA Cardiol; 2021 Nov; 6(11):1267-1274. PubMed ID: 34431962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study.
    Madhani A; Sabogal N; Massillon D; Paul LD; Rodriguez C; Fine D; Helmke S; Winburn M; Kurian D; Raiszadeh F; Teruya S; Cohn E; Einstein AJ; Miller EJ; Connors LH; Maurer MS; Ruberg FL
    J Am Heart Assoc; 2023 Aug; 12(15):e028973. PubMed ID: 37486082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
    Arvanitis M; Koch CM; Chan GG; Torres-Arancivia C; LaValley MP; Jacobson DR; Berk JL; Connors LH; Ruberg FL
    JAMA Cardiol; 2017 Mar; 2(3):305-313. PubMed ID: 28196196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy.
    Maestro-Benedicto A; Vela P; de Frutos F; Mora N; Pomares A; Gonzalez-Vioque E; Briceño A; Cabrera E; Cobo-Marcos M; Dominguez F; Gonzalez-Lopez E; Segovia J; Lara-Pezzi E; Garcia-Pavia P
    Eur J Heart Fail; 2022 Dec; 24(12):2367-2373. PubMed ID: 35999650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care resource use, diagnostic delay and disease burden in transthyretin amyloid cardiomyopathy in Sweden.
    Hjalte F; Norlin JM; Alverbäck-Labberton L; Johansson K; Wikström G; Eldhagen P
    Ann Med; 2023; 55(2):2292686. PubMed ID: 38096896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges.
    Bruno M; Castaño A; Burton A; Grodin JL
    Heart Fail Rev; 2021 Jan; 26(1):35-45. PubMed ID: 32794090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of transthyretin amyloid cardiomyopathy in patients admitted for acute heart failure.
    Spaccavento A; Rodríguez MDR; Meretta A; Elissamburu P; Carvelli V; Gobbo M; Rosa D; Masoli O; Conde D; Costabel JP
    Curr Probl Cardiol; 2024 Mar; 49(3):102385. PubMed ID: 38184135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases.
    Damy T; Bourel G; Slama M; Algalarrondo V; Lairez O; Fournier P; Costa J; Pelcot F; Farrugia A; Zaleski ID; Lilliu H; Rault C; Bartoli M; Fievez S; Granghaud A; Rudant J; Coste A; Cosson CN; Squara PA; Narbeburu M; De Neuville B; Charron P
    Orphanet J Rare Dis; 2023 Nov; 18(1):345. PubMed ID: 37926810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transthyretin Amyloid Cardiomyopathy Risk Evaluation in a Cohort of Patients With Heart Failure.
    Suh AA; Shaw PB; Jeong MY; Olson KL; Delate T
    Perm J; 2023 Jun; 27(2):51-60. PubMed ID: 36970848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough advances enhancing care in ATTR amyloid cardiomyopathy.
    Porcari A; Sinagra G; Gillmore JD; Fontana M; Hawkins PN
    Eur J Intern Med; 2024 May; 123():29-36. PubMed ID: 38184468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, clinical characteristics, and diagnostic approach in transthyretin amyloid cardiomyopathy: The Kumamoto Cardiac Amyloidosis Survey.
    Takashio S; Tokitsu T; Matsukawa M; Sakaino N; Fujimoto K; Sakamoto T; Noda K; Tsunoda R; Misumi I; Hirai N; Doi H; Koide S; Mizuno Y; Hirose T; Kurokawa H; Kajiwara I; Ohba K; Miyamoto S; Araki S; Yamamoto E; Matsushita K; Ueda M; Tsujita K;
    J Cardiol; 2022 Jul; 80(1):49-55. PubMed ID: 35078683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, incidence and clinical outcomes of epicardial coronary artery disease among transthyretin amyloidosis cardiomyopathy patients.
    Hassan R; Miller RJH; Howlett JG; White JA; Fine NM
    BMC Cardiovasc Disord; 2023 Mar; 23(1):124. PubMed ID: 36890444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Early Hereditary Transthyretin Amyloid Cardiomyopathy Recognition With Genetic Screening: A Case Report.
    Juarez M; Del Rio-Pertuz G; Parmar K; Bois MC; Shurmur S; Argueta-Sosa E
    J Prim Care Community Health; 2022; 13():21501319211062682. PubMed ID: 34983267
    [No Abstract]   [Full Text] [Related]  

  • 20. Evolving epidemiology of transthyretin amyloid cardiomyopathy due to increased recognition in women.
    Prasad M; Kim M; Chandrashekar P; Zhao Y; Fischer KL; Nazer B; Masri A
    Int J Cardiol; 2023 Mar; 374():116-119. PubMed ID: 36587655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.